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ABSTRACT
Community-associated methicillin-resistant Sta-
phylococcus aureus isolates characteristically
contain the genes for Panton–Valentine leukoci-
din (PVL), which is a proposed virulence factor.
To determine whether different alleles of the PVL
genes lukS-PV and lukF-PV occur, and whether
they are associated with specific genetic lineages
of S. aureus, sequences from 28 S. aureus isolates,
representing four different multilocus sequence
types, and bacteriophages SLT and PVL were
compared. Seven nucleotide polymorphisms were
identified, which defined three groups of the
lukS-PV and lukF-PV sequence. Only one poly-
morphism resulted in an amino-acid change.
Bacteriophage SLT and isolates of bacteriophage
type 80 ⁄ 81 contained the prototypic (founder)
lukS-PV and lukF-PV sequence. The alleles were
not lineage-specific.
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Staphylococcus aureus has long been considered to
be a major healthcare-associated pathogen, but
has gained significant notoriety in recent years as
a threat to healthy individuals in the community
[1]. Community-associated methicillin-resistant
S. aureus (CA-MRSA) is now a global concern
and is endemic in a variety of countries, including
the USA, European countries, Australia and New
Zealand [2]. Although multilocus sequence typing
has shown that geographically disparate CA-
MRSA strains are often genetically distinct, e.g.,
ST80 (Europe), ST1 and ST8 (USA), ST30 (south-
west Pacific), and ST5 and ST45 (Australia), an
important shared feature of most isolates is the
production of Panton–Valentine leukocidin (PVL)
[3]. PVL is encoded by two co-transcribed genes,
lukS-PV and lukF-PV, associated with bacterio-
phages such as /SLT and /PVL [4–6], which
integrate into the host chromosome. Horizontal
transfer of the lukS-PV and lukF-PV genes
between S. aureus strains mediated by /SLT has
been reported [4].
Allelic variation has been described for several
bacterial genes whose products are highly anti-
genic and are thus targets of the infected host’s
immunological response (e.g., Streptococcus pyo-
genes M protein [7], Streptococcus pneumoniae
autolysin [8] and Helicobacter pylori flagellin [9]).
The aim of the present study was to investigate
whether allelic variation is present among
lukS-PV and lukF-PV sequences from S. aureus
isolates with diverse genetic backgrounds. These
included CA-MRSA isolates such as MW2 (ST1)
[10], USA300 (ST8) [11] and ST80 [12], and
methicillin-susceptible S. aureus isolates of
bacteriophage type 80 ⁄ 81 that are similar to
pandemic strains of the 1950s [13] (Table 1).
Sequences were also determined for the lukS-PV-
and lukF-PV-containing bacteriophages /SLT and
/PVL.
Chromosomal DNA was isolated according to
the method of Enright et al. [14]. Sequencing was
accomplished using the following PCR primers,
designed to target the lukS-PV and lukF-PV
contiguous sequence of /SLT (GenBank accession
number AB045978, nucleotides 40767–42684):
PVL4F (nucleotides 40788–40807, 5¢-GCTGCAA-
CATTGTCGTTAGG); PVL2R (nucleotides 41969–
41989, 5¢-TGTCTTTTGGATTTGGCTTTG); and
PVL1R (nucleotides 42612–42632, 5¢-TGATT
TTCCCAATCAACTTCA). PCR amplification
was performed in a total volume of 100 lL
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containing 0.2 mM dNTP mix, 1.5 mM MgCl2,
0.5 lM each primer, 2.5 U of Taq DNA Polymer-
ase (Roche, Mannheim, Germany) and 1 lL of
template DNA (c. 1 lg). Amplification comprised
30 cycles of 95C for 30 s, 55C for 30 s and 72C
for 2 min, with a final extension at 72C for
7 min. PCR products were separated by electro-
phoresis in agarose (SeaKem LE; FMC Bio-
products, Rockland, ME, USA) 1.5% w ⁄ v gels
and visualised with ethidium bromide staining.
Amplification products were purified with
the Microcon Centrifugal Filter Device YM-50
(Millipore, Billerica, MA, USA), used according to
the manufacturer’s instructions, and were then
sequenced using an ABI Prism 3100 Avant
Genetic Analyzer (Applied Biosystems, Foster
City, CA, USA).
Comparative analysis of lukS-PV and lukF-PV
sequences showed the presence of seven single
nucleotide polymorphisms (SNPs) among the
various S. aureus strains tested (Table 1). Within
the 1918-bp PVL sequence, four SNPs were
identified in lukS-PV (nucleotides 1–939) and
three were identified in lukF-PV (nucleotides
941–1918). Only one SNP (nucleotide 527, AﬁG)
resulted in an amino-acid substitution, of arginine
for histidine at position 176. This amino-acid
change increased the predicted molecular size of
LukS from 35 294 Da (His176) to 35 313 Da
(Arg176), and the theoretical isoelectric point from
9.1 (His176) to 9.2 (Arg176). Whether this change
affects the conformational structure of the protein
is presently unknown. Interestingly, Arg176 was
associated primarily with more recent CA-MRSA
isolates from the USA (ST8 USA300 and ST1
USA400), while His176 was associated with the
European CA-MRSA ST80, ST30 USA1100, and
the older bacteriophage type 80 ⁄ 81 isolates such
as U9NO (Table 1).
The lukS-PV and lukF-PV SNPs were analysed
with a minimum spanning tree constructed using
BioNumerics v.4.1 (Applied Maths, Sint-Martens-
Table 1. Location of single nucleotide polymorphisms (SNPs) in Panton–Valentine leukocidin gene sequences
Isolatea MLST
PFTb ⁄ strain
designation
SNP locationc
Sourcee
lukS-PV lukF-PV
216 345 527d 663 1046 1396 1729
469 U9NO (80 ⁄ 81) C C A G G A A [18]
1123 ST30 PS80 C C A G G A A [19]
1257 ST30 USA1100 C C A G G A A CDC
1258 ST30 USA1100 C C A G G A A CDC
AB045978 /SLT C C A G G A A
1197 ST80 DK 188851-95 C T A G G A A SSI
1198 ST80 DK 11819-97 C T A G G A A SSI
1199 ST80 DK 1413-01 C T A G G A A SSI
1200 ST80 DK 3022-01 C T A G G A A SSI
1201 ST80 DK 4300-01 C T A G G A A SSI
1202 ST80 DK 649-03 C T A G G A A SSI
1209 ST80 DK 2347-03 C T A G G A A SSI
1211 ST80 DK E31-97 C T A G G A A SSI
1213 ST80 DK HT0490 C T A G G A A SSI
1214 ST80 DK Gre14 C T A G G A A SSI
1216 ST80 DK 02-1418 C T A G G A A SSI
1251 ST1 USA400 C C A G G G A CDC
BA00033 ST1 USA400 (MW2) C C G T G A A [10]
1252 ST1 USA400 C C G T G A A CDC
1254 ST1 USA400 C C G T G A A CDC
1255 ST1 USA400 C C G T G A A CDC
CP000255 ST8 USA300 C C G T G A G [20]
1134 ST8 USA300 C C G T G A G CDC
1136 ST8 USA300 C C G T G A G CDC
1138 ST8 USA300 C C G T G A G CDC
1143 ST8 USA300 C C G T G A G CDC
1145 ST8 USA300 C C G T G A G CDC
1148 ST8 USA300 C C G T G A G CDC
1128 ST8 USA300 C C G T T A G CDC
AB009866 /PVL T C A G G G A
aStock strain number or GenBank accession number.
bPulsed-field type (PFT) as described by McDougal et al. [21].
cLocation of SNPs within lukS-PV and lukF-PV. Numbers represent nucleotide position within the entire 1918-bp sequence. Differences from the founder sequence are
indicated by bold type.
dSNP resulting in an amino-acid change: His176 (A) or Arg176 (G).
eSSI, Statens Serum Institute, Copenhagen, Denmark; CDC, Centers for Disease Control and Prevention, Atlanta, GA, USA.
MLST, multilocus sequence typing.
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Latem, Belgium). Linkage priorities were
assigned in order of decreasing importance to
types with: (i) the highest number of single-locus
(i.e. base-pair) variants; (ii) the highest number of
double-locus variants; and (iii) the highest num-
ber of samples belonging to a single type. Three
divergent sequence groups were identified, as
shown in Fig. 1.
The common lukS-PV and lukF-PV sequence
from /SLT, S. aureus U9NO (bacteriophage type
80 ⁄ 81), both ST30 USA1100 isolates (also known
as the south-west Pacific clone) and S. aureus PS80
was identified as the founder sequence, consistent
with the proposed role of these strains as the
progenitor of more recent CA-MRSA isolates [13].
Currently, most GenBank entries for PVL ⁄ lukS-
PV and lukF-PV contain this sequence (data not
shown).
Although isolated over an 8-year period (1995–
2003), the isolates belonging to the predominant
CA-MRSA strain in Europe (ST80) all contained
the same single SNP variation from the founder
sequence. A second group contained one of the
ST1 USA400 isolates (1251), with a single SNP,
and /PVL with an additional SNP variation
from the founder sequence. The third lukS-PV
and lukF-PV group contained the remaining four
ST1 USA400 isolates and all eight of the ST8
USA300 isolates tested, suggesting the presence
of a shared PVL-encoding bacteriophage. The
lukS-PV and lukF-PV sequence in these USA400
isolates, which included the prototype strain
MW2, was related most closely to the founder
sequence (i.e., showed two SNPs, including the
AﬁG His176 to Arg176 substitution). All but one
of the USA300 isolates in this group differed by
one SNP from USA400, and by three SNPs
from the founder sequence. Another ST8
USA300 isolate (1128) contained an additional
SNP, perhaps suggesting an evolutionary pro-
gression, at least among CA-MRSA strains within
the USA.
The role of PVL in the pathogenesis of CA-
MRSA infections remains controversial [15–17].
Nevertheless, the presence of the lukS-PV and
lukF-PV loci is a well-established characteristic of
CA-MRSA strains. On the basis of analysis of
this limited number of isolates, lukS-PV and
lukF-PV sequences appear to be conserved with a
limited number of SNPs (resulting in primarily
synonomous changes), suggesting that the
association between the PVL genes (lukS-PV
and lukF-PV) and CA-MRSA is more than
coincidental. Nevertheless, additional studies
(potentially including the issue of amino-acid
substitution noted here) are clearly required to
further clarify the role that lukS-PV and lukF-PV
may play, particularly in the pathogenesis of
CA-MRSA infections.
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ABSTRACT
In total, 120 Escherichia coli isolates positive for one
of the gentamicin resistance (GENR) genes aac(3)-
II, aac(3)-IV or ant(2¢¢)-I were tested for gentamicin
susceptibility by the agar dilution method. Isolates
positive for aac(3)-IV or ant(2¢¢)-I had an MIC
distribution of 8–64 mg ⁄L, whereas isolates posit-
ive for aac(3)-II had MICs of 32 to >512 mg ⁄L,
suggesting a relationship between the distribution
of MICs and the specific GENR mechanism. The
MIC distribution, regardless of the GENR mech-
anism, was 8 - >512 mg ⁄L, which supports the
clinical breakpoint of MIC >4 mg ⁄L suggested by
EUCAST and questions the breakpoint recom-
mended by the CLSI (‡16 mg ⁄L).
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Gentamicin was introduced in 1963 as the first
clinically useful broad-spectrum antimicrobial
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